Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan Jones

Showing results (201-210 of 278) with videos related to

Pageof 28
Sort By:
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|November 16, 2025
Trials evaluating nicorandil renoprotection against contrast-induced nephropathy after coronary angiography or percutaneous coronary intervention: a systematic review and meta-analysisNestor Lemos Ferreira, Débora Regina Aguiar, Sachin G Nair, et al.
Cancer|October 2, 2010
Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia: a randomized trial of frontline high-dose imatinib mesylate with or without pegylated interferon alpha-2b and granulocyte-macrophage colony-stimulating factorJorge Cortes, Alfonso Quintás-Cardama, Dan Jones, et al.
Molecular Cytogenetics|September 2, 2014
Submicroscopic deletion of 5q involving tumor suppressor genes (CTNNA1, HSPA9) and copy neutral loss of heterozygosity associated with TET2 and EZH2 mutations in a case of MDS with normal chromosome and FISH resultsMorteza Hemmat, Weina Chen, Arturo Anguiano, et al.
Genes, Chromosomes & Cancer|November 13, 2009
Modeling interactions between leukemia-specific chromosomal changes, somatic mutations, and gene expression patterns during progression of core-binding factor leukemiasDan Jones, Hui Yao, Angela Romans, et al.
Blood|September 24, 2008
BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome-positive leukemiasDan Jones, Rajyalakshmi Luthra, Jorge Cortes, et al.
Cancer|January 20, 2007
Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemiaYasuhiro Oki, Hagop M Kantarjian, Vazganush Gharibyan, et al.
Cancer Journal (Sudbury, Mass.)|November 6, 2002
Radiotherapy alone for lymphocyte-predominant Hodgkin's diseasePamela J Schlembach, Richard B Wilder, Dan Jones, et al.
Cancer|August 13, 2009
Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutationWeina Chen, Sergej Konoplev, L Jeffrey Medeiros, et al.
Histopathology|December 21, 2010
Large B cell lymphoma presenting initially in bone marrow, liver and spleen: an aggressive entity associated frequently with haemophagocytic syndromeYu-Min Yeh, Kung-Chao Chang, Ya-Ping Chen, et al.
Leukemia & Lymphoma|November 21, 2008
Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science studyEric D Hsi, Sin-Ho Jung, Raymond Lai, et al.
Pageof 28

Showing results (201-210 of 278) with videos related to

Sort By:
Pageof 28
The Egyptian Heart Journal : (EHJ) : Official Bulletin of the Egyptian Society of Cardiology|November 16, 2025
Trials evaluating nicorandil renoprotection against contrast-induced nephropathy after coronary angiography or percutaneous coronary intervention: a systematic review and meta-analysisNestor Lemos Ferreira, Débora Regina Aguiar, Sachin G Nair, et al.
Cancer|October 2, 2010
Immune modulation of minimal residual disease in early chronic phase chronic myelogenous leukemia: a randomized trial of frontline high-dose imatinib mesylate with or without pegylated interferon alpha-2b and granulocyte-macrophage colony-stimulating factorJorge Cortes, Alfonso Quintás-Cardama, Dan Jones, et al.
Molecular Cytogenetics|September 2, 2014
Submicroscopic deletion of 5q involving tumor suppressor genes (CTNNA1, HSPA9) and copy neutral loss of heterozygosity associated with TET2 and EZH2 mutations in a case of MDS with normal chromosome and FISH resultsMorteza Hemmat, Weina Chen, Arturo Anguiano, et al.
Genes, Chromosomes & Cancer|November 13, 2009
Modeling interactions between leukemia-specific chromosomal changes, somatic mutations, and gene expression patterns during progression of core-binding factor leukemiasDan Jones, Hui Yao, Angela Romans, et al.
Blood|September 24, 2008
BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome-positive leukemiasDan Jones, Rajyalakshmi Luthra, Jorge Cortes, et al.
Cancer|January 20, 2007
Phase II study of low-dose decitabine in combination with imatinib mesylate in patients with accelerated or myeloid blastic phase of chronic myelogenous leukemiaYasuhiro Oki, Hagop M Kantarjian, Vazganush Gharibyan, et al.
Cancer Journal (Sudbury, Mass.)|November 6, 2002
Radiotherapy alone for lymphocyte-predominant Hodgkin's diseasePamela J Schlembach, Richard B Wilder, Dan Jones, et al.
Cancer|August 13, 2009
Cuplike nuclei (prominent nuclear invaginations) in acute myeloid leukemia are highly associated with FLT3 internal tandem duplication and NPM1 mutationWeina Chen, Sergej Konoplev, L Jeffrey Medeiros, et al.
Histopathology|December 21, 2010
Large B cell lymphoma presenting initially in bone marrow, liver and spleen: an aggressive entity associated frequently with haemophagocytic syndromeYu-Min Yeh, Kung-Chao Chang, Ya-Ping Chen, et al.
Leukemia & Lymphoma|November 21, 2008
Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science studyEric D Hsi, Sin-Ho Jung, Raymond Lai, et al.
Pageof 28